When a childs medical record documents recurrent hospitalizations, multiple specialists, complex medication regimens, or the use of durable medical equipment (DME), review whether underlying chronic conditions have been captured with specificity (e.g., type and severity of asthma, specific sickle cell variant, exact chromosomal disorder)
The conclusion is especially strong for metabolic outcomes, because randomized comparisons, network meta-analysis, and multiple reviews point in the same direction
However, not everyone is suited for tirzepatide treatment
Pfizer says the study is open for enrollment
Albiglutide was associated with fewer hypoglycemic events and moderate weight loss, but Albiglutide based on fusion protein technology produced more antibodies due to its functional protein domain
These medications are not FDA-approved and have not undergone FDA pre-market review for safety, efficacy, or quality